Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy

Leber's hereditary optic neuropathy (LHON) is a disease that leads to blindness. Gene therapy has been investigated with some success, and could lead to important advancements in treating LHON. This was a prospective, open-label trial involving 9 LHON patients at Tongji Hospital, Wuhan, China,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shuo, Ma, Si-qi, Wan, Xing, He, Heng, Pei, Han, Zhao, Min-jian, Chen, Chen, Wang, Dao-wen, Dong, Xiao-yan, Yuan, Jia-jia, Li, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006665/
https://www.ncbi.nlm.nih.gov/pubmed/27426279
http://dx.doi.org/10.1016/j.ebiom.2016.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006665/
https://www.ncbi.nlm.nih.gov/pubmed/27426279
http://dx.doi.org/10.1016/j.ebiom.2016.07.002

Ejemplares similares